For how we live.
Short trials show topical hyaluronic acid improves skin hydration and, in low-molecular-weight forms, wrinkle depth. It is a humectant on the surface, not a replacement for the acid skin loses with age.
For most adults who bruise more than they used to, the cause is thinner skin from ageing, sun or steroids, plus the aspirin and anticoagulants many older people take. A few patterns point elsewhere.
The flaky, red patches on scalp, brows and nose folds are an inflammatory reaction, not poor hygiene. Ketoconazole cream cut treatment failure 31% against placebo, and short steroid courses tripled clearance.
The brown facial patches come from overactive pigment cells in sun-aged skin. Triple-combination cream beats hydroquinone alone (risk ratio 1.58) and tranexamic acid helps, but relapse is the rule.
The bumps are plugged hair follicles, not dirt or a deficiency. Keratolytics help modestly and temporarily: lactic acid cut lesions 66% and salicylic acid 52% over 12 weeks, but they return when you stop.
Chronic hives are mast-cell driven and usually have no external trigger. Antihistamines clear some cases; at 12 weeks omalizumab cut a weekly itch score by 9.8 points at 300 mg, against 5.1 on placebo.
Topical vitamin C is a real antioxidant that helps skin build collagen. Split-face studies show measurable smoothing, but a systematic review found only seven usable trials, almost all mixing it with other actives.
Rubbing ice on your face constricts vessels for a moment, but a controlled cold study found lower skin hydration and more redness, not firmer skin — and prolonged cold makes vessels reopen.
The trials behind facial masks are small, brief and mostly run by the products' makers. They can show a real hydration and comfort effect — but not the lasting anti-ageing results on the packaging.
A split-face melasma trial put niacinamide within reach of prescription hydroquinone with fewer side effects. But much of the anti-ageing evidence comes from the ingredient's own manufacturers.
Topical retinol is the over-the-counter cousin of prescription tretinoin. In the cleanest test of the pure ingredient, three-times-a-week retinol beat its own vehicle on fine wrinkles and built new collagen — slowly.
'Natural', 'clean' and 'organic' have no agreed regulatory meaning on a cosmetic label, and some plant-derived and fragrance ingredients are among the most common triggers of allergic skin reactions.
The beauty claims for silk pillowcases — fewer wrinkles, less acne, smoother hair — have no direct trials behind them. The most rigorous test of silk fabric on skin, in eczema, found it added nothing.
The chronic skin disease is often missed for years. In a cohort of 507 women, those who kept up topical steroid treatment developed no vulval cancers; those who did not had a 4.7% rate.
Red-light masks and panels promise photorejuvenation without lasers or needles. A randomised trial of 136 volunteers backs the collagen claim — but it is one good study, and 'red light' covers very different devices.
A high number does buy measurably more protection — in one real-use trial far fewer people burned on the SPF 100 side. But how much you apply, and whether you reapply, moves the needle more than the label.
A head-to-head trial found both tools nudged facial measurements over eight weeks, but the effects were small, mechanical and short-lived. There is no evidence they 'sculpt' the face or drain toxins.
Sun-driven brown patches are hard to shift. A Cochrane review found a triple-combination cream beat hydroquinone alone; newer meta-analyses point to tranexamic acid and PRP, on thinner evidence.
The belief that a razor makes hair return coarser, faster or darker is one of medicine's durable myths. Controlled studies going back decades find no change in thickness, colour or growth rate.
For dry, eczema-prone skin and for shielding hair from wash damage, coconut oil has real randomised evidence behind it — narrow, not miraculous, and not the same claim as being good for every skin type.
These soft flaps are harmless. Their real interest is metabolic — one study tied them to diabetes with an odds ratio of 1.89 — but a 2026 cohort found no link to prediabetes. Removal is cosmetic, not a home job.
Chronic hives can flare for months with no allergy to find. A Cochrane review of 9,759 people found modern antihistamines such as cetirizine clear them in a minority, not everyone.
In the one randomised trial to test it, adults who used sunscreen daily showed no detectable increase in skin ageing over 4.5 years — 24% less than those who used it as they pleased.
Xerosis is a barrier problem, not dirt. Cochrane found moisturisers cut eczema flares 60% and spared steroid use; in care-home residents a twice-daily emollient roughly halved skin tears, on weak evidence.
Pooled randomised trials show real improvements in skin hydration and elasticity versus placebo, but the effect is moderate, the measures are instrument readings, and the evidence base is shaky.
One in five people get chronic itch at some point. When no rash and no cause turn up, a Cochrane review found almost no trials at all — leaving guideline experts to work from indirect evidence.
Collagen, flavanols and polyphenols beat their comparators on skin elasticity and sun tolerance. The pooled estimates carry heterogeneity of 95% to 98%, and some comparators were low doses of the same ingredient.